Turtle Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -32.17%
- Profit Growth -178.13%
- Ebitda -203.62%
- Net Worth -63.54%
- Total Assets -3.38%
About Turtle Pharma
Turtle Pharma Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2015 (Nine years and ten months 29 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Himani Hiran, Tatva Hiran, and Payal Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900MH2015PTC262688
-
Company No.
262688
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Mar 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Turtle Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himani Hiran
|
Director | 13-Mar-2015 | Current |
|
Tatva Hiran
|
Director | 07-Oct-2023 | Current |
|
Payal Shah
|
Director | 01-Dec-2017 | Current |
Financial Performance of Turtle Pharma.
Turtle Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.17% decrease. The company also saw a substantial fall in profitability, with a 178.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Turtle Pharma?
In 2023, Turtle Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jackrabbit Exports Private LimitedHimani Hiran, Tatva Hiran and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Turtle Pharma?
Unlock and access historical data on people associated with Turtle Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Turtle Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Turtle Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
